The global cardiovascular devices market was valued at over $55 billion in 2017. Read More: https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report-2018

1. Cardiovascular Devices
Global Market Report 2018
Including: Cardiovascular Surgery Devices; Cardiac Rhythm Management (CRM) Devices; Interventional
Cardiology Devices; Defibrillator Devices; Peripheral Vascular Devices; Prosthetic Heart Valve Device;
Electrophysiology Devices; Cardiac Assist Devices
Covering: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., Edwards
Lifesciences
Feb 2018

2. Reasons to Purchase
• Outperform competitors using accurate up to date demand-side dynamics
information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the
drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high
quality data and analysis
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 3-5
working days of order.
Markets Covered: Cardiovascular Surgery Devices; Cardiac Rhythm Management (CRM)
Devices; Interventional Cardiology Devices; Defibrillator Devices; Peripheral Vascular
Devices; Prosthetic Heart Valve Device; Electrophysiology Devices; Cardiac Assist Devices
Companies Mentioned: Medtronic plc, Abbott Laboratories, Boston Scientific
Corporation, Cardinal Health Inc., Edwards Lifesciences
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and
Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita,
Cardiovascular Devices Indicators Comparison.
Data segmentations: Country and regional historic and forecast data, market share of
competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end
notes.
Scope

3. Cardiovascular Devices Market
Characteristics
Cardiovascular devices are designed to diagnose, prevent, monitor and treat
diseases related to the cardiovascular system Including heart diseases and related
health problems. They include arrhythmia detectors, noninvasive blood pressure
measurement systems, diagnostic intravascular catheters, external cardiac
compressors, coronary vascular physiologic simulation software devices, external
programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary
bypass defoamers, echocardiographs, vascular graft prostheses,
electrocardiographs, defibrillators and others.
The cardiovascular devices market in this report is segmented into cardiovascular
surgery devices, cardiac rhythm management (CRM) devices, interventional
cardiology devices, defibrillator devices, peripheral vascular devices, prosthetic
heart valve device, electrophysiology devices and cardiac assist devices
Cardiovascular Surgery Devices
Cardiovascular surgery devices are used in
Cardiac Rhythm Management (CRM) Devices
These devices are used to manage the heart rate or
Interventional Cardiology Devices
Interventional cardiology devices are used in
Defibrillator Devices
Defibrillator Devices are used in the
Peripheral Vascular Devices
Peripheral vascular devices are used to

4. Prosthetic Heart Valve Devices
Electrophysiology Devices are used in the diagnosis and treatment of
Cardiac Assist Devices are artificial mechanic pumps that assist the heart in
In this report market value is defined as the revenues organizations earn by selling
their goods and services within the specified market, based on the price at which
they sell. Only goods and services traded between entities are included.
The revenues for a specified geography are consumption values – that is, they are
revenues generated by organizations in the specified geography within the
specified market, irrespective of where they are produced.

5. Cardiovascular Devices Market
Historic Growth
The global cardiovascular devices market grew from $X billion in 2013 to $X billion
in 2017 at a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global
cardiovascular devices market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:

6. Cardiovascular Devices Market
Forecast Growth
The global cardiovascular devices market is expected to grow from $XX billion in
2017 to $61.4 billion in 2021 at a compound annual growth rate (CAGR) of XX%.
The chart and table below shows the year-on-year growth of the global
cardiovascular devices market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:

7. Cardiovascular Devices Market
Segmentation
The chart and table below shows the split of the cardiovascular devices market in
2017.

8. The total market value for cardiovascular devices was $X billion in 2017. The
markets that are covered include Cardiovascular Surgery Devices; Cardiac Rhythm
Management (CRM) Devices; Interventional Cardiology Devices; Defibrillator
Devices; Peripheral Vascular Devices; Prosthetic Heart Valve Device;
Electrophysiology Devices; Cardiac Assist Devices.
Cardiovascular Surgery Devices was the X largest segment in the cardiovascular
devices market with X% share of the market. The market value for the
cardiovascular surgery devices was $X billion in 2017.
Cardiac Rhythm Management (CRM) Devices made up around X% share of the
market. The market value for the cardiac rhythm management (CRM) Devices was
$X billion in 2017.

9. Cardiovascular Devices Market
Regional And Country Analysis
The Asia Pacific was the largest region in the cardiovascular devices market in 2017,
cardiovascular devices for $X billion or X% market share.
North America was the x largest region cardiovascular devices for $X billion or X%
market share.
Western Europe was the x largest region cardiovascular devices for $X billion or X%
market share.

10. Cardiovascular Devices Market
Competitive Landscape
The leading competitors in the global cardiovascular devices market are Medtronic
plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc.,
Edwards Lifesciences.
The chart and table below displays the percentage market share of the top players
in the cardiovascular devices market industry.
Medtronic plc generated revenues of $XX billion for the financial year 2016, an
XX% increase from the previous year.
Abbott Laboratories generated revenues of $XX billion for the financial year 2016,
an XX% decrease from the previous year.
Boston Scientific Corporation generated revenues of $XX billion for the financial
year 2016, an XX% increase from the previous year.
Cardinal Health, Inc. generated revenues of $XX billion for the financial year 2016,
an XX% increase from the previous year.

11. Edwards Lifesciences generated revenues of $XX billion for the financial year
2016, an XX% increase from the previous year.
Terumo Corporation generated revenues of $XX billion for the financial year 2016,
an XX% increase from the previous year.
B. Braun Holding GmbH & Co. KG generated revenues of $XX billion for the
financial year 2016, an XX% increase from the previous year.
Johnson & Johnson Inc. generated revenues of $XX billion for the financial year
2016, an XX% decrease from the previous year.
C.R. Bard, Inc. (U.S.) generated revenues of $XX billion for the financial year 2016,
an XX% increase from the previous year.
Company Profile
Medtronic plc
Overview
Medtronic was the largest company in the cardiovascular devices market in
2017, with an XX% share of the market. It is a medical technology, services
and solutions company and serves hospitals, physicians, clinicians and
patients in approximately 160 countries worldwide. Medtronic was founded
in 1949 and is headquartered in Dublin, Ireland.
Products and Services
The company operates through the following divisions-
The Cardiac and Vascular group caters to
The Minimally Invasive Technologies Group provides
The Restorative Therapies group provides
The Diabetes Group consists of

12. Strategy
Medtronic’s growth strategy is to capture untapped business opportunities
in emerging markets through acquisitions. For instance, In January 2015,
Medtronic acquired Covidien Plc for $49.9 Billion in cash. This deal gives
Medtronic the Covidien’s portfolio of cardiac and vascular devices,
Financial Performance
Medtronic’s cardiac and vascular group division involved in the
cardiovascular devices manufacturing, generated revenues of $XX billion
for the financial year 2017, a XX% increase from the previous year. The
company had a market
Abbott Laboratories
Overview
Products and Services
Strategy
Financial Performance
Boston Scientific Corporation
Overview
Products and Services
Strategy
Financial Performance
Cardinal Health Inc.
Overview
Products and Services
Strategy
Financial Performance
Edwards Lifesciences
Overview
Products and Services
Strategy
Financial
Performance